What is BioIQ?
Founded in 2005 and headquartered in Atlanta, Georgia, BioIQ operates at the intersection of digital health and diagnostic testing. The company provides a sophisticated software platform designed to streamline the connection between individuals and health testing services. By simplifying the logistics of health screenings, BioIQ enhances accessibility for patients while simultaneously creating valuable touch points for health service partners. This dual-sided value proposition positions the firm as an essential utility in the shift toward proactive, data-driven health management.
How much funding has BioIQ raised?
BioIQ has raised a total of $46.5M across 6 funding rounds:
Other Financing Round
$436K
Other Financing Round
$492K
Private Equity
$10M
Private Equity
$7.1M
Unspecified
$26.5M
Debt
$2M
Other Financing Round (2009): $436K with participation from Persistence Partners
Other Financing Round (2010): $492K led by Persistence Partners
Private Equity (2015): $10M, investors not publicly disclosed
Private Equity (2016): $7.1M, investors not publicly disclosed
Unspecified (2018): $26.5M backed by HealthQuest Capital and Arboretum Ventures
Debt (2020): $2M with participation from PPP
Key Investors in BioIQ
HealthQuest Capital
HealthQuest Capital is a venture capital firm dedicated to investing in innovative healthcare companies that improve patient outcomes and reduce costs.
Arboretum Ventures
Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience in investing in innovative healthcare solutions, focusing on early-stage startups in under-ventured markets.
Persistence Partners
Persistence Partners is an early-stage venture fund that focuses on funding entrepreneurial teams capable of leveraging technology to solve problems and grow businesses.
What's next for BioIQ?
With the support of its latest capital infusion, BioIQ is well-positioned to accelerate its enterprise-level expansion. The company is expected to focus on deepening its integration with health service providers and enhancing its diagnostic software capabilities to meet the rising demand for remote and accessible health monitoring. As the healthcare industry continues to prioritize patient-centric digital solutions, BioIQ's strategic roadmap likely involves scaling its operational footprint and refining its data analytics to provide deeper insights into population health trends. The firm remains a key entity to watch as it navigates the complexities of the evolving digital health landscape.
See full BioIQ company page
